Vendor profile Research · US · —

Mai Peptide

B+
Composite 7.8 / 10

Last updated 2026-10-26. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
6.0
Fair
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
Retatrutide
8.7B+
8.4 40 — — — — view
GHK-Cu
8.4B+
8.2 15 — — — — view
Ipamorelin
8.0B+
7.6 8 — — — — view
Tirzepatide
7.0B
6.3 29 — — — — view
Tesamorelin
6.2C
5.9 7 — — — — view
BPC-157
5.5C
4.5 6 — — — — view
PT-141
—
— 0 — — — — view
CJC-1295
—
3.6 3 — — — — view
Semaglutide
—
5.9 2 — — — — view
TB-500
—
3.7 3 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Mai Peptide against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.